Boston Scientific: latest news - GoINPHARMA
Monday, 22 April 2019 - 21:16

Boston Scientific

Boston Scientific announces acquisition of BTG for GBP3.3bn

US-based medical devices producer Boston Scientific has acquired its UK-based competitor BTG for GBP3.3bn. Boston Scientific has valued BTG 840p per share, which means a premium 36% over Monday’s closing price. The move will strengthen Boston Scientific’s position in the…

Boston Scientific acquires Augmenix for $600m

Boston Scientific (Massachusetts) has announced the acquisition of Augmenix, Inc. for $600m. As part of the agreement, Boston Scientific will pay Augmenix an upfront $500m, plus an additional $100m subject to fulfillment of precise milestones. Augmenix is headquartered in Bedford,…

Boston Scientific to acquire Switzerland’s Symetis for $435m (TAVR)

Boston Scientific Corp announced it has acquired Switzerland-based Symetis SA for $435m. Symetis ranks fourth globally in the replacement of heart valves – more specifically, TAVR (Transcatheter Aortic Valve Replacement). Symetis’ top brand is Acurate, which will join Boston Scientific’s…